MAPT and Alzheimer disease: Recent studies demonstrate that both toxic AβOs structures and toxic oligomers Tau (TauOs) can initiate prionoid-like neurodegenerative phenomena in AD; these toxic intracellular and extracellular oligomers and less amyloid plaques and NFTs are in the near future the target of new pharmacotherapies [46,47,48,49].